Skip to main content
  • Monitoring New-Onset AF Immediately Post-TAVR Could Be Necessary Strategy: Large-Scale Meta-Analysis

    Monitoring for new-onset atrial fibrillation (NOAF) should be considered as a strategy after transcatheter aortic valve replacement (TAVR) as a common and risky complication, though whether it is a causal factor or a marker of “sicker patients” remains unclear, according to a new meta-analysis.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details